Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma
Authors
Keywords
-
Journal
BLOOD
Volume 121, Issue 2, Pages 318-328
Publisher
American Society of Hematology
Online
2012-11-21
DOI
10.1182/blood-2012-06-436220
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients
- (2012) N Hosen et al. LEUKEMIA
- Pathogenesis of Myeloma
- (2011) Kenneth C. Anderson et al. Annual Review of Pathology-Mechanisms of Disease
- Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications
- (2011) J. Jakubikova et al. BLOOD
- Molecular functions of syndecan-1 in disease
- (2011) Yvonne Hui-Fang Teng et al. MATRIX BIOLOGY
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of HLA Class II Molecules in Humanized NOD.Rag1KO.IL2RgcKO Mice Is Critical for Development and Function of Human T and B Cells
- (2011) Rebecca Danner et al. PLoS One
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells
- (2010) A. Caraux et al. HAEMATOLOGICA
- Plasma cell development and survival
- (2010) Sarah A. Oracki et al. IMMUNOLOGICAL REVIEWS
- The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo
- (2009) H. Ikeda et al. CLINICAL CANCER RESEARCH
- Non-genetic heterogeneity of cells in development: more than just noise
- (2009) S. Huang DEVELOPMENT
- International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
- (2009) R Fonseca et al. LEUKEMIA
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Cancer attractors: A systems view of tumors from a gene network dynamics and developmental perspective
- (2009) Sui Huang et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Mechanism and Regulation of Class Switch Recombination
- (2008) Janet Stavnezer et al. Annual Review of Immunology
- Analysis of clonotypic switch junctions reveals multiple myeloma originates from a single class switch event with ongoing mutation in the isotype-switched progeny
- (2008) B. J. Taylor et al. BLOOD
- Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells
- (2008) D. C. Taussig et al. BLOOD
- Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance
- (2008) W. Matsui et al. CANCER RESEARCH
- CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma
- (2008) E. D. Hsi et al. CLINICAL CANCER RESEARCH
- Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
- (2008) A. C. Rawstron et al. HAEMATOLOGICA
- Multiple Myeloma Cancer Stem Cells
- (2008) Carol Ann Huff et al. JOURNAL OF CLINICAL ONCOLOGY
- Transcriptome-wide noise controls lineage choice in mammalian progenitor cells
- (2008) Hannah H. Chang et al. NATURE
- Phenotypic and functional heterogeneity of human memory B cells
- (2008) Iñaki Sanz et al. SEMINARS IN IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started